about
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseBudesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trialsOsteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune responseMechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applicationsMechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cellsCD44 deficiency attenuates chronic murine ileitis.A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis.Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis.Short-term study of infliximab treatment for Crohn's disease in China.Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes.Stem cells as potential therapeutic targets for inflammatory bowel disease.Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.Role of the endothelium in inflammatory bowel diseases.Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis.Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond.Therapeutic modulation of inflammatory gene transcription by kinase inhibitors.Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trialGene transfer approaches for the treatment of inflammatory bowel disease.Potential new drugs for therapy of chronic obstructive pulmonary disease.Emerging biotherapies for inflammatory bowel disease.Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individualsG Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal InflammationIL-10 and its related cytokines for treatment of inflammatory bowel disease.Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.Pharmacogenetics and inflammatory bowel disease: progress and prospects.Obstructive fibrostenotic Crohn's disease.Maintenance of remission in Crohn's disease.Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitisPlecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.Effects of Rheum tanguticum polysaccharide on TNBS -induced colitis and CD4+T cells in ratsUbiquitin protein modification and signal transduction: implications for inflammatory bowel diseases.A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in miceCarbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathwayReview article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.Management consensus of inflammatory bowel disease for the Asia-Pacific region.Safety of biologic therapy.Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patientsClinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients.
P2860
Q24680126-CBA0A6C8-E6EF-4F0E-B7CE-D041F03E4BE3Q28266279-33A04DD7-B312-4C2F-A56C-4845B4E35646Q28267161-5C830CA5-3F3B-49A6-9B64-837DF6D26F8EQ28282507-96AE466E-358E-4F63-85AA-260BFD7C5F9CQ28287701-AD785BF8-B413-4A76-A7AC-C251BA845CB7Q30405358-CEF8BE3C-06C4-4E95-8E02-749EE605C32EQ30433247-A27195B0-4AB2-4D46-8CAC-964B3D39077BQ30439952-326918F9-C2CA-47A6-9F81-6916C042B340Q33394485-91D2FE2F-586D-4439-B724-1A4371E4D664Q33509456-95F460DD-E894-4624-961F-D3455EAA619DQ33975300-66149FA5-4DAB-4636-BE7C-01FD3B19CAB2Q34110714-60EE3A7F-6E0D-45BC-B901-8116C83A195AQ34579746-B8259CEE-5587-4C11-B05A-7B0233859522Q34606191-8A7408AD-2800-49BB-9C45-99FE8E886C4FQ34615408-32A8B0D1-8BD3-4C6E-AC8D-415715A20AFAQ34779788-D36FD55F-DB1C-469E-999F-AEC93585F327Q35010988-26772C03-B00A-45C6-AB16-EEDA7B18FBA3Q35122162-6AFAF179-DAA2-4688-9CCF-B699783CCD7CQ35164728-7C37AA3E-37E1-43EE-A642-691FCD39BA17Q35602638-097C69E6-11BD-492D-8854-E5627639A677Q35663886-0B6AB5FB-2E97-4A62-86AD-8ACF961D7696Q35670785-76F5F767-003E-4C35-9F8D-7ACC05B7F25DQ35678651-FF9D7098-F7CC-4AA4-90E8-0705057B0E40Q35692276-3C686A18-3569-42E7-8DE1-56A4077E1C28Q35787609-04ACBA66-2971-434E-BF6D-93413D687192Q36041712-68F58C86-CCD3-47C9-BB64-8E687D77C611Q36041732-88420552-6A35-45A6-B9A5-C39F41019973Q36054928-5C4EAAC8-EEE0-4A12-AB7E-569D6AD2E75BQ36180541-0204BB0A-F8F4-48A2-B5E0-BE8D0C755669Q36193382-79A38A33-7069-4803-9C5A-9B677BD36248Q36254155-290B494A-9693-4CB9-ACFB-EFBAAF78074DQ36308707-D9120329-2D09-4D64-911F-B3CFE159E6EDQ36321691-745B8023-9A80-4131-832D-49BCBF668C15Q36344230-032261F5-61E8-43EB-BDE0-6E74D6106431Q36403089-EBDD7F8A-C975-44DA-80B6-6386620A51E0Q36589413-2F539814-D8A9-4F63-811D-590C52A63466Q36639081-9F405F69-4ACA-430A-AF28-1473212265D9Q36737339-6321BFB7-DA0D-43C7-8DE1-118D46668E88Q36795649-755533EF-F1AA-45D9-AD57-DDDEB356AE63Q36819607-353ECD3B-D472-4CF0-8E2E-FBA84A993468
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Biologic therapy of inflammatory bowel disease.
@ast
Biologic therapy of inflammatory bowel disease.
@en
Biologic therapy of inflammatory bowel disease.
@nl
type
label
Biologic therapy of inflammatory bowel disease.
@ast
Biologic therapy of inflammatory bowel disease.
@en
Biologic therapy of inflammatory bowel disease.
@nl
prefLabel
Biologic therapy of inflammatory bowel disease.
@ast
Biologic therapy of inflammatory bowel disease.
@en
Biologic therapy of inflammatory bowel disease.
@nl
P356
P1433
P1476
Biologic therapy of inflammatory bowel disease.
@en
P2093
Stephan R Targan
P304
P356
10.1053/GAST.2002.33426
P407
P577
2002-05-01T00:00:00Z